tailieunhanh - ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer

ADAM12-L and ADAM12-S represent two major splice variants of human metalloproteinase-disintegrin 12 mRNA, which differ in their 3′-untranslated regions (3′UTRs). ADAM12-L, but not ADAM12-S, has prognostic and chemopredictive values in breast cancer. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN